Zoll Medical Corporation

Zoll Medical Corporation, a foreign-owned for-profit manufacturer headquartered in Chelmsford, Massachusetts, operates as a federal prime contractor in medical device supply, competing on full-and-open federal procurements without set-aside designations across 171 distinct customer agencies. The vendor supplies defibrillators, patient monitoring systems, electrodes, batteries, ventilators, and related emergency medical equipment to Department of Defense, Department of Veterans Affairs, and civilian federal healthcare systems.

Zoll's federal footprint is heavily concentrated in consumable medical supplies and equipment delivery. Over the past five years, the vendor has received 52,407 total awards—nearly all prime contracts (100% of portfolio)—with combined potential value of $16.5 billion, though only $1.52 billion (9%) has been obligated to date. Activity has remained stable between 5,100 and 6,200 awards per year from 2022 to 2025, with 2,055 awards recorded through mid-2026. Representative recent work includes a $2.63 million purchase order from Veterans Integrated Service Network 9 for ZOLL defibrillators (awarded June 2026), a $93,303 order from Veterans Integrated Service Network 4 for Zoll Zenix Series Advanced Defibrillators with multi-parameter monitoring and training (awarded June 2026), and a $29,351 purchase order from the U.S. Coast Guard for a patient monitor for Air Station Astoria search-and-rescue operations (awarded April 2026). The vendor also supplied automated external defibrillators to the Department of State's Bureau of African Affairs for use in Burundi (awarded April 2026, $18,361).

Customer concentration sits overwhelmingly with the Defense Logistics Agency Troop Support Medical division, which accounts for 47,879 awards and $3.95 billion in combined potential value—92% of the award count and approximately 24% of all potential value across the portfolio. The Department of Veterans Affairs Veterans Health Administration dominates the remaining customer base, with Veterans Integrated Service Network 12 holding $56.5 million in combined potential value across 71 awards, followed by smaller volumes across Veterans Integrated Service Networks 15, 17, 10, 16, and 19. The Department of the Navy Bureau of Medicine and Surgery, with 200 awards valued at $7 million combined, rounds out the top tier.

Zoll holds positions on multiple DLA indefinite delivery contracts anchoring the federal medical supply chain. The primary vehicle is Indefinite Delivery Contract SPE2D119D7003, under which 31,828 task orders carry $295.6 million in combined potential value. Two additional DLA IDCs—SPM2D113D8220 (6,449 task orders, $147.1 million) and SPE2D118D7003 (5,398 task orders, $135.9 million)—represent the second and third largest parent vehicles. Zoll also holds a Federal Supply Schedule position (36F79725D0033) under the Department of Veterans Affairs' Medical Equipment and Supplies schedule, valued at $23.4 million through December 2029, with geographic coverage spanning the continental United States, Alaska, Hawaii, and Puerto Rico. Task orders under this FSS vehicle include a $82,112 order for R Series defibrillators from Veterans Integrated Service Network 6 (completion June 2025) and a $5,265 order for defibrillators from the Department of State's Bureau of European and Eurasian Affairs (completion March 2026). The DLA Medical Capital Equipment Program represents an additional 1,912 task orders valued at $147.4 million combined.

The vendor faces modest recompete exposure within the next twenty-four months, with 783 awards totaling $16.9 million in combined potential value reaching ultimate completion before mid-2028. Zoll's subcontractor footprint is minimal—only two sub-awards appear in recent data: a March 2026 task order under Bering Straits Professional Services for consequence management support services in support of the Air National Guard CBRNE mission, and a February 2025 grant sub-award under Cincinnati University for advanced development of autonomous closed-loop control mechanical ventilation. The vendor operates through three named subsidiaries: Zoll Data Systems, Inc., Zoll Respicardia Inc., and Zoll Laboratory Services LLC, all foreign-owned for-profit organizations.

Zoll's business model relies on high-volume, low-dollar transactional ordering against pre-established vehicles—the median award value is substantially sub-million—distributed through the federal medical supply ecosystem. The vendor competes exclusively on full-and-open procurements and has not pursued set-aside categories across any segment of its prime portfolio.